Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

3030 - Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Tumour Site

Head and Neck Cancers

Presenters

Hiromichi Shirasu

Citation

Annals of Oncology (2018) 29 (suppl_8): viii372-viii399. 10.1093/annonc/mdy287

Authors

H. Shirasu1, T. Yokota1, K. Fushiki1, H. Inoue1, M. Shibata1, M. Furuta1, T. Kawakami1, S. Kawai2, S. Hamauchi1, A. Todaka1, T. Tsushima1, N. Machida3, K. Yamazaki1, A. Fukutomi1, Y. Onozawa1, H. Yasui1

Author affiliations

  • 1 Division Of Gastrointestinal Oncology, Shizuoka Cancer Center, 411-8777 - Shizuoka/JP
  • 2 Division Of Medical Oncology, Shizuoka Cancer Center, 411-8777 - Shizuoka/JP
  • 3 Division Of Gastrointestinal Oncology, Shizuoka Cancer Center, 4118777 - Shizuoka/JP

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 3030

Background

Aspiration pneumonia (AP) is one of the most important side effects in chemoradiotherapy (CRT) and bio-radiotherapy (BRT) for patients (pts) with head and neck cancer (HNC). AP is involved in on-cancer related mortality in HNC pts. However, the relation between AP during CRT or BRT and treatment outcomes in HNC pts has not been identified. The aims of this study were to assess the influence of AP on treatment outcomes, and to identify clinical risk factors for AP during definitive CRT or BRT for HNC pts.

Methods

We retrospectively assessed the data of pts with locally advanced HNC who received definitive CRT or BRT at Shizuoka Cancer Center (August 2006 to December 2016). AP was defined as a clinical condition that met all the following criteria: (i) pts with both subjective and objective symptoms of pneumonia; (ii) the presence of aspiration was suspected clinically (choking or delayed swallowing) or by endoscopy or video-fluorography exams; (iii) no evidence of micro-organisms that cause atypical pneumonia.

Results

Of 374 HNC pts who received CRT or BRT, 95 (25.4%) developed AP during treatment. The study cohort of 374 pts had the following features: median age 65 years (range: 19-83); male/female, 322/52; performance status 0/1/2/3, 196/109/14/3; number of metastatic sites 1/2/3/4, 98/60/27/4; primary site larynx/nasopharynx/nasal-sinus/oropharynx/oral-cavity/ear-canal, 57/48/132/21/101/14/1; T-classification 1/2/3/4a/4b, 32/136/86/92/28; N-classification (UICC 7th) 0/1/2a/2b/2c/3, 76/54/19/134/75/16; induction chemotherapy -/+, 273/101; chemotherapy regimen cisplatin/carboplatin/cetuximab, 278/64/32. AP was significantly associated with treatment response of CRT or BRT (multivariate-adjusted odds ratio for complete response 0.55, p < 0.029). Multivariate analyses identified four independent factors for AP, including poor oral hygiene, high N-classification, hypoalbuminemia before treatment, and inpatient treatment.

Conclusions

AP during CRT or BRT has a detrimental effect on treatment response in HNC pts. Careful attention should be paid to AP in HNC pts with these risk factors receiving CRT or BRT.

Clinical trial identification

Legal entity responsible for the study

H. Shirasu.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.